====== Pembrolizumab ======

Pembrolizumab (formerly lambrolizumab, brand name Keytruda) is a [[humanized antibody]] used in cancer [[immunotherapy]]. This includes treating [[melanoma]], [[lung cancer]], [[head and neck cancer]], [[Hodgkin lymphoma]], and stomach cancer. It is given by slow injection into a vein.
----
anti-[[PD-1]] drug (monoclonal antibody to PD-1 programmed cell death receptor): [[pembrolizumab]] (Keytruda) approved for advanced or unresectable melanoma not responding to other drugs
((U.S. Food and Drug Administration (FDA). FDA approves Keytruda for advanced melanoma. 2014. https://wayback.archive-it.org/7993/ 20170112023823/http://www.fda.gov/ NewsEvents/Newsroom/PressAnnouncements/ ucm412802.htm)).


===== Pembrolizumab for non-Small-cell lung cancer =====

[[Pembrolizumab for non-Small-cell lung cancer]]. 

===== Pembrolizumab for glioblastoma =====

[[Pembrolizumab for glioblastoma]].


===== References =====